Saint Germain les Arpajon, France

Olivier Gremy

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivier Gremy: Innovator in Chelation Technology

Introduction

Olivier Gremy is a notable inventor based in Saint Germain les Arpajon, France. He has made significant contributions to the field of chelation technology, particularly through his innovative patent. His work focuses on the development of systems that enhance the delivery of chelators for radionuclides and metals.

Latest Patents

Olivier Gremy holds a patent titled "Use of a reverse-micellar system for delivering chelators of radionuclides and metals." This invention relates to reverse-micellar systems that comprise an active agent, acylglycerol, sterol, lecithin, ethanol, and water. These systems are designed for the chelation and sequestering of radionuclides and metals in patients. The patent also encompasses pharmaceutical compositions that utilize these reverse-micellar systems.

Career Highlights

Gremy is associated with Medesis Pharma, a company that focuses on innovative pharmaceutical solutions. His work at Medesis Pharma has allowed him to explore and develop advanced technologies in drug delivery systems. His contributions have been instrumental in enhancing the efficacy of treatments involving radionuclides and metals.

Collaborations

Olivier Gremy collaborates with talented professionals in his field, including Caroline Bauer and Elsa Compte. These collaborations have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Olivier Gremy is a pioneering inventor whose work in chelation technology has the potential to significantly impact medical treatments. His patent and contributions to Medesis Pharma highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…